Browsing Over 32 Presentations

Sort By
Treatment of newly diagnosed ovarian cancer: Where are we in 2021 and what’s next? Educational session

Live Q&A and discussion (ID 7)

Lecture Time
14:35 - 14:50
Session Name
Treatment of newly diagnosed ovarian cancer: Where are we in 2021 and what’s next?
Location
Channel 1, Virtual Meeting, Vienna, Austria
Date
Fri, 25.06.2021
Time
13:35 - 14:50
Best of abstracts session Abstract session

Discussion (ID 34)

Lecture Time
13:05 - 13:15
Speakers
  • E. C. Kohn (Bethesda, United States of America)
Session Name
Best of abstracts session
Location
Channel 1, Virtual Meeting, Vienna, Austria
Date
Sat, 26.06.2021
Time
12:45 - 14:15
How to deal with the different challenges in your professional career YO Session

How to deal with social media - Self-representation and networking (ID 29)

Lecture Time
17:50 - 18:00
Speakers
  • D. S. Dizon (Providence, United States of America, RI)
Session Name
How to deal with the different challenges in your professional career
Location
Channel 1, Virtual Meeting, Vienna, Austria
Date
Fri, 25.06.2021
Time
17:50 - 19:05
Best of abstracts session Abstract session

Long term safety and secondary efficacy end points in the ENGOT-OV16/NOVA phase 3 trial on Niraparib in recurrent ovarian cancer (ID 24)

Lecture Time
12:55 - 13:05
Speakers
  • M. Mirza (Copenhagen, Denmark)
Session Name
Best of abstracts session
Location
Channel 1, Virtual Meeting, Vienna, Austria
Date
Sat, 26.06.2021
Time
12:45 - 14:15
Immunotherapy in ovarian cancer: Is there a future in clinical practice? Controversy session

No (ID 19)

Lecture Time
16:30 - 16:45
Speakers
  • K. N. Moore (Oklahoma City, United States of America, Oklahoma)
Session Name
Immunotherapy in ovarian cancer: Is there a future in clinical practice?
Location
Channel 1, Virtual Meeting, Vienna, Austria
Date
Sat, 26.06.2021
Time
16:00 - 17:00
Treatment and biomarkers of recurrent ovarian cancer: Where are we in 2021 and what’s next? Educational session

Do all patients with recurrent ovarian cancer need systemic therapy and which is the optimal treatment algorithm? (ID 14)

Lecture Time
14:50 - 15:10
Speakers
  • M. L. Friedlander (Randwick, Australia)
Session Name
Treatment and biomarkers of recurrent ovarian cancer: Where are we in 2021 and what’s next?
Location
Channel 1, Virtual Meeting, Vienna, Austria
Date
Sat, 26.06.2021
Time
14:30 - 15:45
1st line maintenance strategy options for advanced ovarian cancer by HRD profile Clinical case session

Clinical case - What options for HR proficient patients? Criteria for treatment choice (ID 9)

Lecture Time
15:25 - 15:45
Speakers
  • N. Colombo (Milan, Italy)
Session Name
1st line maintenance strategy options for advanced ovarian cancer by HRD profile
Location
Channel 1, Virtual Meeting, Vienna, Austria
Date
Fri, 25.06.2021
Time
15:05 - 16:20
Treatment of newly diagnosed ovarian cancer: Where are we in 2021 and what’s next? Educational session

The role of surgery for newly diagnosed ovarian cancer: Current status and future directions (ID 4)

Lecture Time
13:50 - 14:05
Speakers
  • S. Mahner (Munich, Germany)
Session Name
Treatment of newly diagnosed ovarian cancer: Where are we in 2021 and what’s next?
Location
Channel 1, Virtual Meeting, Vienna, Austria
Date
Fri, 25.06.2021
Time
13:35 - 14:50
How to deal with the different challenges in your professional career YO Session

How to seize opportunities and progress your career in the gynae-oncology field (ID 31)

Lecture Time
18:10 - 18:20
Speakers
  • C. Sessa (Bellinzona, Switzerland)
Session Name
How to deal with the different challenges in your professional career
Location
Channel 1, Virtual Meeting, Vienna, Austria
Date
Fri, 25.06.2021
Time
17:50 - 19:05
Authors
  • C. Sessa (Bellinzona, Switzerland)
Best of abstracts session Abstract session

Rucaparib vs chemotherapy in patients with advanced, relapsed ovarian cancer and a deleterious BRCA mutation: Efficacy and safety from ARIEL4, a randomized phase 3 study (ID 26)

Lecture Time
13:30 - 13:40
Speakers
  • R. Kristeleit (London, United Kingdom)
Session Name
Best of abstracts session
Location
Channel 1, Virtual Meeting, Vienna, Austria
Date
Sat, 26.06.2021
Time
12:45 - 14:15
Welcome to ESMO Gynae 2021 and Keynote address Opening and closure session

Live welcome (ID 21)

Lecture Time
12:45 - 12:50
Speakers
  • S. Banerjee (London, United Kingdom)
  • D. Lorusso (Rome, Italy)
  • A. Poveda Velasco (Valencia, Spain)
Session Name
Welcome to ESMO Gynae 2021 and Keynote address
Location
Channel 1, Virtual Meeting, Vienna, Austria
Date
Fri, 25.06.2021
Time
12:45 - 13:20
Treatment and biomarkers of recurrent ovarian cancer: Where are we in 2021 and what’s next? Educational session

Live Q&A and discussion (ID 16)

Lecture Time
15:30 - 15:45
Session Name
Treatment and biomarkers of recurrent ovarian cancer: Where are we in 2021 and what’s next?
Location
Channel 1, Virtual Meeting, Vienna, Austria
Date
Sat, 26.06.2021
Time
14:30 - 15:45